SVFC Financials 07/15/2014 20:12:46 Intellicell B

SVFC Financials 07/15/2014 20:12:46
Intellicell Biosciences, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - 535 99 -
Cost of Revenue - 435 51 -
Gross Profit - 100 48 -
Operating Expenses
Research and Development 442 292 222 285
Sales, General and Admin. 5,079 14,510 17,858 2,026
Non-Recurring Items - - - -
Other - - - -
Operating Income (5,521) (14,702) (18,032) (2,310)
Income From Continuing Operations
Add'l Income/Expense Items (5,230) 10,763 (14,503) (880)
Earnings Before Interest and Tax (10,751) (3,939) (32,535) (3,190)
Interest Expense 390 213 304 665
Earnings Before Tax (11,141) (4,152) (32,839) (3,855)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (11,141) (4,152) (32,839) (3,855)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (11,141) (4,152) (32,839) (3,855)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (11,141) (4,152) (32,839) (3,855)